Neurotrope, Inc. NTRP Balance Sheet

Neurotrope, inc. (NTRP)

Balance Sheet / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jul'13	Apr'13	Jan'13	Dec'12	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Jan'11
ASSETS
CURRENT ASSETS
Cash and cash equivalents
17,400	18,901	21,255	24,032	28,854	9,743	11,819	14,499	16,113	18,650	21,465	23,765	25,773	6,515	8,958	10,070	11,230	1,543	3,390	5,477	8,010	10,065	11,951	13,569	15,211	15,556	0	1	3	0	1	3	0	5	10	12	8
Prepaid expenses
494	983	796	426	603	1,231	1,155	231	310	431	179	132	138	209	97	617	1,489	347	75	56	97	-	-	-	87	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses - Related party
-	-	-	-	-	-	-	-	-	-	-	-	-	14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Subscription receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	154	95	78	-	92	-	-	-	0	-	-	-	-	-	-	-
Accounts Receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	5	-	0	-	-
TOTAL CURRENT ASSETS
17,876	19,885	22,052	24,458	29,457	10,975	12,975	14,730	16,423	19,081	21,645	23,897	25,912	6,739	9,056	10,687	12,723	1,891	3,465	5,534	8,107	10,220	12,047	13,647	15,298	15,649	0	1	3	0	1	3	5	5	10	12	8
Fixed assets, net of accumulated depreciation
21	22	24	25	20	21	22	19	20	21	22	22	55	56	58	59	59	60	62	55	53	48	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
TOTAL ASSETS
17,897	19,908	22,076	24,484	29,478	10,996	12,997	14,750	16,444	19,103	21,667	23,920	25,967	6,796	9,114	10,747	12,782	1,952	3,527	5,589	8,161	10,268	12,047	13,647	15,298	15,649	0	1	3	0	1	3	5	5	10	12	8
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable
413	725	795	997	2,898	1,484	870	946	1,240	1,617	2,131	1,877	2,167	1,401	699	469	449	1,010	852	963	778	-	-	-	119	-	-	-	-	-	-	-	-	-	-	-	-
Note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	2	10	18	26	-	0	-	-	-	-	-	12	12	8	-	6	2	-	0	-	-	-
Accounts payable and accrued expenses - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	251	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable - related party
-	-	-	-	-	112	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	303	0	115	-	49	-	-	-	1,240	-	-	-	-	-	-	-
Accrued expenses
65	58	56	60	58	89	145	202	268	50	52	56	190	199	178	55	141	333	345	56	310	-	-	-	37	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	200	977	537	162	-	82	0	0	1	192	0	2	3	0	0	0	3
Accrued expenses - related party
-	-	-	-	-	25	75	25	50	0	0	12	4	352	351	351	389	236	200	0	0	-	-	-	-	0	-	-	-	4	-	-	-	-	-	-	-
TOTAL CURRENT LIABILITIES
479	784	852	1,058	2,957	1,711	1,091	1,174	1,558	1,667	2,183	1,946	2,362	1,953	1,229	879	990	1,598	1,424	1,019	1,289	1,281	537	277	408	132	12	-	9	1,437	-	-	-	-	-	-	-
Commitments and contingencies
-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0	-	-	-	-	-	-	-
Convertible redeemable preferred stock, Series A, $.0001 par value, 50,000,000 shares authorized; 16,755,894 and 21,363,000 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively. Liquidation preference of $16,755,894 plus dividends accruable at 8% per annum of $3,139,966 as of September 30, 2015 and Liquidation preference of $21,363,000 plus dividends accruable at 8% per annum of $2,687,835 at December 31, 2014
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,522	14,736	16,267	-	19,639	19,811	19,811	19,943	18,971	-	-	-	0	-	-	-	-	-	-	-
TOTAL SHAREHOLDERS' EQUITY
Preferred stock - 100,000 shares authorized, $0.0001 par value; 0 shares issued and outstanding as of December 31, 2019 and December 31, 2018
0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock - 150,000,000 shares authorized, $0.0001 par value; 13,068,023 shares issued and outstanding as of December 31, 2019; 12,922,370 shares issued and outstanding as of December 31, 2018
1	1	1	1	1	0	0	0	0	0	0	0	0	0	4	4	0	2	2	2	0	2	2	2	2	2	2	-	2	2	-	-	-	-	-	-	-
Total liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	-	-	6	4	3	0	0	0	3
Common Stock Authorized: 300,000,000 common shares, $0.0001 par value. Issued and outstanding shares: 10,200,000 common shares at April 30, 2013 and January 31, 2013.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	1	1	1	1	1	1	0
Additional paid-in capital
106,234	105,325	103,601	101,795	100,202	79,224	78,676	78,224	77,544	75,783	75,535	75,080	73,648	28,909	28,304	27,946	27,700	11,019	10,662	8,948	6,630	5,234	4,442	4,277	3,974	3,779	18	19	18	0	19	19	19	19	19	19	8
Stock Subscription Receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	1
Accumulated deficit
-88,816	-86,203	-82,378	-78,371	-73,682	-69,940	-66,770	-64,648	-62,659	-58,349	-56,052	-53,106	-50,044	-35,637	-32,045	-29,852	-27,724	-25,190	-23,298	-20,648	-18,282	-15,888	-12,746	-	-9,029	-	-	-33	-	-	-25	-22	-19	-15	-11	-9	-3
Deficit accumulated during the development stage
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,719	-	7,236	33	-	27	1,439	-	-	-	-	-	-	-
TOTAL SHAREHOLDERS' EQUITY
17,418	19,123	21,224	23,425	26,521	9,285	11,906	13,576	14,885	17,435	19,483	21,973	23,604	-6,727	-3,735	-1,901	-23	-14,168	-12,633	-11,697	-11,652	-10,651	-8,301	-6,440	-5,053	-3,454	-12	-12	-6	-1,437	-4	-1	1	5	9	11	4
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
17,897	19,908	22,076	24,484	29,478	10,996	12,997	14,750	16,444	19,103	21,667	23,920	25,967	6,796	9,114	10,747	12,782	1,952	3,527	5,589	8,161	10,268	12,047	13,647	15,298	15,649	0	1	3	0	1	3	5	5	10	12	8